Insomnia

Psychiatry·MeSH: Sleep Initiation and Maintenance Disorders

11 drugs in development·9 companies·17 clinical trials

Drug Pipeline by Phase

Approved(7)

Drug	Company
Belsomra	Merck & Co., Inc. (MRK)
compound schizandra	Fuss Brands Corp. (FBDS)
edluar	Viatris Inc (VTRS)
huoliyuan	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
siberian ginseng series	Fuss Brands Corp. (FBDS)
silenor	PERNIX THERAPEUTICS HOLDINGS, INC. (PTX)
zolpidem	Teva Pharmaceutical Industries Limited (TEVA)

Phase 3(2)

Drug	Company
hec83518	SUNSHINE BIOPHARMA INC. (SBFM)
Suvorexant	Merck & Co., Inc. (MRK)

Preclinical(2)

Drug	Company
ART12.11	ARTELO BIOSCIENCES, INC. (ARTL)
nhāler	Rapid Therapeutic Science Laboratories, Inc. (RTSL)

BioSniper tracks 11 drugs in development for Insomnia across 9 companies.

There are 17 clinical trials targeting Insomnia tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.